UVA Health’s Post

University of Virginia School of Medicine and Brain Institute researchers have received an initial $9.3 million award from The National Institutes of Health to determine if the powerful anesthetic ketamine can save patients from prolonged, life-threatening grand mal seizures. 🔬 Learn more: https://bit.ly/3EpYHqU

  • Person in a lab coat smiling at the camera in a laboratory environment, with text overlay stating "UVA Receives $9.3 Million to Test Ketamine Against Deadly Epileptic Seizures" and the UVA Health logo displayed.
Francis X. Farrell

Senior Director, Research and Development Carilion Clinic

2mo

Congratulations Dr Kapur

Like
Reply
Cindy Reynolds, FAHP, CFRE

Health care philanthropy strategist, fractional foundation exec, board development, author, public speaker.

2mo

Jaideep Kapur what an exciting development for you and UVA’s amazing epilepsy program - and all the patients who will benefit from your findings. Congratulations!

Like
Reply
Mahendra Chordia

Senior Research Scientist at University of Virginia

1mo

Congratulations!

Like
Reply
Jody K. Reyes, FACHE, MSBA, BSN

Chief Operating Officer, Clinical Enterprise | University of Iowa Health Care

2mo

Wonderful

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics